Pöldinger W, Gammel G
Int Pharmacopsychiatry. 1978;13(1):58-68. doi: 10.1159/000468322.
A double-blind study comparing the effects of nomifensine and nortriptyline, which was carried out exclusively on outpatients with retarded depressions, showed nomifensine to have a distinctive antidepressive and activating effect. 40 patients (17 male and 23 female) with either endogenous, endogenous/psychogenic or psychogenic depression were divided into two treatment groups (20 patients to each group). During the 21-day study, all patients were given three 50 mg capsules of nomifensine or nortriptyline per day. With the aid of a depression scale, a significant improvement in the psychic symptoms was noted both in the nomifensine and the nortriptyline group. There was no evidence of a significant difference in the two drugs. The data obtained from the dropouts suggest that nomifensine had a better effect. From the results of the study, it can be concluded that nomifensine is suitable for the treatment of patients with retarded depressions.
一项仅针对迟发性抑郁症门诊患者进行的比较诺米芬辛和去甲替林效果的双盲研究表明,诺米芬辛具有独特的抗抑郁和激活作用。40例患有内源性、内源性/心因性或心因性抑郁症的患者(17例男性和23例女性)被分为两个治疗组(每组20例患者)。在为期21天的研究期间,所有患者每天服用三粒50毫克的诺米芬辛或去甲替林胶囊。借助抑郁量表,诺米芬辛组和去甲替林组的精神症状均有显著改善。没有证据表明这两种药物存在显著差异。从退出研究的患者所获得的数据表明,诺米芬辛的效果更好。从研究结果可以得出结论,诺米芬辛适用于治疗迟发性抑郁症患者。